SCHEMBL19126474

SCHEMBL19126474

COC(=O)Cn1ccc2cc(N=[N+]=[N-])ccc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 1/20 0.50
▸ MTNR1A P48039 1/20 0.39
▸ MTNR1B P49286 1/20 0.39
▸ HDAC8 Q9BY41 2/20 0.37
▸ HDAC6 Q9UBN7 2/20 0.37
▸ HDAC11 Q96DB2 1/20 0.37
▸ NTSR1 P30989 3/20 0.36
▸ PLA2G4A P47712 1/20 0.36
▸ TUBB4A P04350 2/20 0.36
▸ TUBB P07437 2/20 0.36
▸ TUBA3C P0DPH7 2/20 0.36
▸ TUBA1B P68363 2/20 0.36
▸ TUBA4A P68366 2/20 0.36
▸ TUBB4B P68371 2/20 0.36
▸ TUBB3 Q13509 2/20 0.36
▸ TUBB2A Q13885 2/20 0.36
▸ TUBB8 Q3ZCM7 2/20 0.36
▸ TUBA3E Q6PEY2 2/20 0.36
▸ TUBA1A Q71U36 2/20 0.36
▸ TUBA1C Q9BQE3 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22042149 0.79 GLO1 (0.43) MTNR1AMTNR1B
SCHEMBL5637363 0.79 ATM (0.56) ATMMTNR1AMTNR1BHDAC8HDAC6
SCHEMBL9200019 0.77 MTNR1A (0.60) ATMMTNR1AMTNR1BHDAC8HDAC6
SCHEMBL5449877 0.77 ATM (0.57) ATMMTNR1AMTNR1BHDAC8HDAC6
SCHEMBL19674140 0.77 ATM (0.57) ATMMTNR1AMTNR1BHDAC8HDAC6
SCHEMBL14876504 0.76 NTSR1 (0.57) ATMMTNR1AMTNR1BHDAC8HDAC6
SCHEMBL21810428 0.76 NTSR1 (0.57) ATMMTNR1AMTNR1BHDAC8HDAC6
SCHEMBL19126497 0.75 LOXL2 (0.43) KDM4EALDH1A1
SCHEMBL14594510 0.75 ATM (0.55) ATMMTNR1AMTNR1BHDAC8HDAC6
SCHEMBL6029964 0.75 ATM (0.58) ATMMTNR1AMTNR1BHDAC8HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11939314-B2 Quinolin-2-one derivatives MERCK PATENT GMBH (DE) 2024-03-26 — — US disclosed
US-20230028687-A1 QUINOLIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2023-01-26 — — US disclosed
US-11186562-B2 Quinolin-2-one derivatives MERCK PATENT GMBH (DE) 2021-11-30 — — US disclosed
US-11174241-B2 Quinolin-2-one derivatives MERCK PATENT GMBH (DE) 2021-11-16 — — US disclosed
CN-108473485-B Quinolin-2-one derivatives 默克专利股份公司 2021-11-02 — — CN disclosed
US-20200190054-A1 QUINOLIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2020-06-18 — — US disclosed
US-20200190055-A1 QUINOLIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2020-06-18 — — US disclosed
US-10669251-B2 Quinolin-2-one derivatives MERCK PATENT GMBH (DE) 2020-06-02 — — US disclosed
US-20190023685-A1 QUINOLIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2019-01-24 — — US disclosed
EP-3402792-A1 QUINOLIN-2-ONE DERIVATIVES Merck Patent GmbH (DE) 2018-11-21 — — EP disclosed
WO-2017121444-A1 QUINOLIN-2-ONE DERIVATIVES MERCK PATENT GMBH (DE) 2017-07-20 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11174241-B2 Quinolin-2-one derivatives KIT, CDK2, CDK1 ATM 419/4885MTNR1A 1953/4885MTNR1B 1834/4885
US-20190023685-A1 QUINOLIN-2-ONE DERIVATIVES KIT, CDK2, CDK1 ATM 419/4885MTNR1A 1953/4885MTNR1B 1834/4885
US-20200190054-A1 QUINOLIN-2-ONE DERIVATIVES KIT, CDK2, CDK1 ATM 419/4885MTNR1A 1953/4885MTNR1B 1834/4885
US-11939314-B2 Quinolin-2-one derivatives KIT, CDK2, CDK1 ATM 419/4885MTNR1A 1953/4885MTNR1B 1834/4885
US-20230028687-A1 QUINOLIN-2-ONE DERIVATIVES KIT, CDK2, CDK1 ATM 419/4885MTNR1A 1953/4885MTNR1B 1834/4885
US-20200190055-A1 QUINOLIN-2-ONE DERIVATIVES KIT, CDK2, CDK1 ATM 419/4885MTNR1A 1953/4885MTNR1B 1834/4885
US-10669251-B2 Quinolin-2-one derivatives KIT, CDK2, CDK1 ATM 419/4885MTNR1A 1953/4885MTNR1B 1834/4885
US-11186562-B2 Quinolin-2-one derivatives KIT, CDK2, CDK1 ATM 419/4885MTNR1A 1953/4885MTNR1B 1834/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback